Search results
Lost Chances to Treat Overdose Survivors Are Documented in New Medicare Study
US News & World Report· 3 days agoInstead, those on Medicare who survived a drug overdose in 2020 were much more likely to later receive opioid painkillers than any medication to treat addiction ...
Health Care Week in Review: House and Senate Reintroduced MA Prior Authorization Bill, and House E&C...
JD Supra· 3 days agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...
Older Americans worry they can’t afford their own health care | CNN
CNN.com· 2 days agoWhat weighs most heavily on older adults’ minds when it comes to health care? “It’s on our minds a...
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
CNBC· 2 days agoMore U.S. employers are covering a buzzy class of medications called GLP-1s for weight loss, a...
California Attorney General Bonta Urges Supreme Court to Uphold States’ Authority to Regulate...
Sierra Sun Times· 4 days agoOAKLAND, CA – California Attorney General Rob Bonta on Wednesday joined a bipartisan coalition of 32...
Congress' angriest poster isn't MTG—it's some old guy from Jersey
The Daily Dot· 1 hour agoPreply sifted through over two million tweets from U.S. representatives, senators, and governors to...
Amazon Pharmacy expands $5 monthly subscription to Medicare patients
AOL· 2 days agoAmazon has worked to lure customers away from more established pharmacies like CVS and Walgreens since launching its pharmacy unit in 2020. With the expansion, Amazon said over 50 million more ...
How Amazon Pharmacy is thinking about 'the messy state' of weight loss drugs
Becker’s Hospital Review· 3 days agoWeight loss drugs were one of the most talked about topics at AHIP's June 2024 conference in Las Vegas, especially with the Amazon Pharmacy team. In March, Eli Lilly tapped ...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Zacks via Yahoo Finance· 6 days agoBiogen/Eisai’s controversial medicine, Aduhelm, was approved by the FDA in 2021. However, in January...
Gateway - Quartz
Quartz· 2 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug